Steroid Treatment Focused Management of Graves’ Ophthalmopathy

Abstract

Graves' disease (GD) is an autoimmune disease that affects the thyroid and the eyes. Graves' ophthalmopathy (GO), an autoimmune disease, usually appears 18 months after GD diagnosis. Clinical activity and disease severity determine the strategy, with steroid treatment recommended during active disease progression.

Keywords

• graves’ disease
• graves’ ophthalmopathy
• graves’ orbitopathy
• glucocorticoids